Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma

Detalhes bibliográficos
Autor(a) principal: MAHONEY, KATHLEEN M.
Data de Publicação: 2016
Outros Autores: JACOBUS, SUSANNA, BHATT, RUPAL S., SONG, JIAXI, CARVO, INGRID, CHENG, SU-CHUN, SIMPSON, MEKAILAH, André Poisl Fay, PUZANOV, IGOR, MICHAELSON, M. DROR, ATKINS, MICHAEL B., MCDERMOTT, DAVID F., SIGNORETTI, SABINA, CHOUEIRI, TONI K.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional PUCRS
Texto Completo: https://hdl.handle.net/10923/21639
id PUCR_71815c3dbbc3fd41c4be26c0253ee809
oai_identifier_str oai:repositorio.pucrs.br:10923/21639
network_acronym_str PUCR
network_name_str Repositório Institucional PUCRS
repository_id_str 2753
spelling MAHONEY, KATHLEEN M.JACOBUS, SUSANNABHATT, RUPAL S.SONG, JIAXICARVO, INGRIDCHENG, SU-CHUNSIMPSON, MEKAILAHAndré Poisl FayPUZANOV, IGORMICHAELSON, M. DRORATKINS, MICHAEL B.MCDERMOTT, DAVID F.SIGNORETTI, SABINACHOUEIRI, TONI K.2022-05-17T14:47:11Z2022-05-17T14:47:11Z20162022-05-17T14:47:10Z1558-7673https://hdl.handle.net/10923/21639DOI:10.1016/j.clgc.2016.02.007Submitted by Biblioteca Suporte PUCRS (biblioteca.suporte@pucrs.br) on 2022-05-17T14:47:11Z No. of bitstreams: 2 Phase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf: 2241166 bytes, checksum: 424ef1f51599b0569c34e5742c437a68 (MD5) Phase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf: 2241166 bytes, checksum: 424ef1f51599b0569c34e5742c437a68 (MD5)Made available in DSpace on 2022-05-17T14:47:11Z (GMT). No. of bitstreams: 2 Phase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf: 2241166 bytes, checksum: 424ef1f51599b0569c34e5742c437a68 (MD5) Phase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf: 2241166 bytes, checksum: 424ef1f51599b0569c34e5742c437a68 (MD5) Previous issue date: 2016Clinical Genitourinary CancerPhase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinomainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleClinical Genitourinary Cancer144304313.e6info:eu-repo/semantics/openAccessengreponame:Repositório Institucional PUCRSinstname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)instacron:PUC_RSTEXTPhase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf.txtPhase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf.txtExtracted texttext/plain42353repositorio.pucrs.br/jspui/bitstream/10923/21639/4/Phase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf.txtd51107e704328c46a66cdf62cd7a3f02MD54ORIGINALPhase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdfapplication/pdf2241166repositorio.pucrs.br/jspui/bitstream/10923/21639/2/Phase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf424ef1f51599b0569c34e5742c437a68MD52SWORDsword-2022-05-17T11:47:05.original.xmlOriginal SWORD entry documentapplication/octet-stream1960repositorio.pucrs.br/jspui/bitstream/10923/21639/1/sword-2022-05-17T11%3A47%3A05.original.xml5929393062cbb7341fe671de80942c82MD51Phase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdfOrignal SWORD deposit fileapplication/pdf2241166repositorio.pucrs.br/jspui/bitstream/10923/21639/3/Phase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf424ef1f51599b0569c34e5742c437a68MD5310923/216392022-05-17 12:00:56.694oai:repositorio.pucrs.br:10923/21639Repositório InstitucionalPRIhttp://repositorio.pucrs.br/oai/request?verb=Identifyopendoar:27532022-05-17T15:00:56Repositório Institucional PUCRS - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)false
dc.title.none.fl_str_mv Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma
title Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma
spellingShingle Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma
MAHONEY, KATHLEEN M.
title_short Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma
title_full Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma
title_fullStr Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma
title_full_unstemmed Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma
title_sort Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma
author MAHONEY, KATHLEEN M.
author_facet MAHONEY, KATHLEEN M.
JACOBUS, SUSANNA
BHATT, RUPAL S.
SONG, JIAXI
CARVO, INGRID
CHENG, SU-CHUN
SIMPSON, MEKAILAH
André Poisl Fay
PUZANOV, IGOR
MICHAELSON, M. DROR
ATKINS, MICHAEL B.
MCDERMOTT, DAVID F.
SIGNORETTI, SABINA
CHOUEIRI, TONI K.
author_role author
author2 JACOBUS, SUSANNA
BHATT, RUPAL S.
SONG, JIAXI
CARVO, INGRID
CHENG, SU-CHUN
SIMPSON, MEKAILAH
André Poisl Fay
PUZANOV, IGOR
MICHAELSON, M. DROR
ATKINS, MICHAEL B.
MCDERMOTT, DAVID F.
SIGNORETTI, SABINA
CHOUEIRI, TONI K.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv MAHONEY, KATHLEEN M.
JACOBUS, SUSANNA
BHATT, RUPAL S.
SONG, JIAXI
CARVO, INGRID
CHENG, SU-CHUN
SIMPSON, MEKAILAH
André Poisl Fay
PUZANOV, IGOR
MICHAELSON, M. DROR
ATKINS, MICHAEL B.
MCDERMOTT, DAVID F.
SIGNORETTI, SABINA
CHOUEIRI, TONI K.
publishDate 2016
dc.date.updated.none.fl_str_mv 2022-05-17T14:47:10Z
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2022-05-17T14:47:11Z
dc.date.available.fl_str_mv 2022-05-17T14:47:11Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10923/21639
dc.identifier.issn.none.fl_str_mv 1558-7673
dc.identifier.doi.none.fl_str_mv DOI:10.1016/j.clgc.2016.02.007
identifier_str_mv 1558-7673
DOI:10.1016/j.clgc.2016.02.007
url https://hdl.handle.net/10923/21639
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Clinical Genitourinary Cancer
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional PUCRS
instname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron:PUC_RS
instname_str Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
instacron_str PUC_RS
institution PUC_RS
reponame_str Repositório Institucional PUCRS
collection Repositório Institucional PUCRS
bitstream.url.fl_str_mv repositorio.pucrs.br/jspui/bitstream/10923/21639/4/Phase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf.txt
repositorio.pucrs.br/jspui/bitstream/10923/21639/2/Phase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf
repositorio.pucrs.br/jspui/bitstream/10923/21639/1/sword-2022-05-17T11%3A47%3A05.original.xml
repositorio.pucrs.br/jspui/bitstream/10923/21639/3/Phase_2_Study_of_Bevacizumab_and_Temsirolimus_After_VEGFR_TKI_in_Metastatic_Renal_Cell_Carcinoma.pdf
bitstream.checksum.fl_str_mv d51107e704328c46a66cdf62cd7a3f02
424ef1f51599b0569c34e5742c437a68
5929393062cbb7341fe671de80942c82
424ef1f51599b0569c34e5742c437a68
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional PUCRS - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
repository.mail.fl_str_mv
_version_ 1747679174013747200

Registros relacionados